Nasdaq Stockholm

Modus Therapeutics Holding AB (publ)

ISIN SE0015987904Filings at the FI

At a glance

Most recent filing on April 24, 2026 — an option exercise by KDventures AB on Apr 24, 2026.

We hold 3 visible filings, going back to October 21, 2021.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

What is a MAR filing?

All 3 shown

This page is free to read, and it stops after 3 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

KDventures AB Closely associated: Chief executive officer, Chair of the board, Board member
5,136,110 SEKOption exercise
TradedApr 24, 2026FiledApr 24, 2026
Claes Lindblad Chief financial officer
13,410 SEKOpen-market buy
TradedDec 1, 2021FiledDec 1, 2021
Karolinska Development AB Closely associated: Chief executive officer, Chair of the board
40,000 sharesAdministrative
TradedOct 21, 2021FiledOct 21, 2021